Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri,Claudiu T. Supuran +1 more
TLDR
Key pH regulators in tumour cells include: isoforms 2, 9 and 12 of carbonic anhydrase, isoforms of anion exchangers, Na+/HCO3− co-transporters, Na+./H+ exchanger, monocarboxylate transporters and the vacuolar ATPase.Abstract:
The high metabolic rate of tumours often leads to acidosis and hypoxia in poorly perfused regions. Tumour cells have thus evolved the ability to function in a more acidic environment than normal cells. Key pH regulators in tumour cells include: isoforms 2, 9 and 12 of carbonic anhydrase, isoforms of anion exchangers, Na+/HCO3- co-transporters, Na+/H+ exchangers, monocarboxylate transporters and the vacuolar ATPase. Both small molecules and antibodies targeting these pH regulators are currently at various stages of clinical development. These antitumour mechanisms are not exploited by the classical cancer drugs and therefore represent a new anticancer drug discovery strategy.read more
Citations
More filters
Journal ArticleDOI
Combination therapy in combating cancer.
Reza Bayat Mokhtari,Reza Bayat Mokhtari,Tina S. Homayouni,Narges Baluch,Evgeniya Morgatskaya,Sushil Kumar,Bikul Das,Herman Yeger +7 more
TL;DR: An approach that combines repurposed pharmaceutical agents with other therapeutics has shown promising results in mitigating tumour burden, and this systematic review discusses important pathways commonly targeted in cancer therapy.
Journal ArticleDOI
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
TL;DR: In this paper, the authors summarize lessons learned from preclinical and clinical studies over the past decade and propose strategies for improving antiangiogenic therapy outcomes for malignant and nonmalignant diseases.
Journal ArticleDOI
The Smart Drug Delivery System and Its Clinical Potential
TL;DR: The recent advances of smart nanoplatforms for targeting drug delivery, including stimuli-responsive polymeric nanoparticles, liposomes, metals/metal oxides, and exosomes are highlighted.
Journal ArticleDOI
Structure and function of carbonic anhydrases
TL;DR: Structural-based drug design campaigns allowed the discovery of highly isoform selective CA inhibitors (CAIs), which may lead to a new generation of drugs targeting these widespread enzymes, and the use of CAs in CO2 capture processes for mitigating the global temperature rise has also been investigated more recently.
Journal ArticleDOI
Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment
TL;DR: This review article summarized the recent progress in various nanoformulations for cancer therapy, with a special emphasis on tumour microenvironment stimuli-responsive ones, which it believes offer a good chance for the practical translation of nanoparticle formulas into clinic.
References
More filters
Journal ArticleDOI
Hallmarks of cancer: the next generation.
TL;DR: Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Journal ArticleDOI
Why do cancers have high aerobic glycolysis
TL;DR: In this article, the authors propose that persistent metabolism of glucose to lactate even in aerobic conditions is an adaptation to intermittent hypoxia in pre-malignant lesions, which leads to microenvironmental acidosis requiring evolution to phenotypes resistant to acid-induced cell toxicity.
Journal ArticleDOI
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
TL;DR: The biological rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases is discussed, and progress in the development of specific modulators of the relevant CA isoforms is highlighted, some of which are now being evaluated in clinical trials.
Journal ArticleDOI
Tumor Cell Metabolism: Cancer's Achilles' Heel
TL;DR: The peculiarities of tumor cell metabolism are reviewed to discuss the alterations in signal transduction pathways and/or enzymatic machineries that account for metabolic reprogramming of transformed cells.
Related Papers (5)
The Carbon Dioxide Hydration Activity of Carbonic Anhydrase I. STOP-FLOW KINETIC STUDIES ON THE NATIVE HUMAN ISOENZYMES B AND C
Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
Yuanmei Lou,Paul C. McDonald,Arusha Oloumi,Stephen Chia,Christina Ostlund,Ardalan Ahmadi,Alastair H. Kyle,Ulrich auf dem Keller,Samuel Leung,David G. Huntsman,Blaise A. Clarke,Brent W. Sutherland,Dawn Waterhouse,Marcel B. Bally,Calvin D. Roskelley,Christopher M. Overall,Andrew I. Minchinton,Fabio Pacchiano,Fabrizio Carta,Andrea Scozzafava,Nadia Touisni,Jean-Yves Winum,Claudiu T. Supuran,Shoukat Dedhar +23 more